Registry Assessment of Peripheral Interventional Devices (RAPID)
Phase II/III Working Group Meeting
Be Part of the Launch Team!
Phase I of RAPID, the 100 minimum core data elements for device evaluation of devices in PAD, was delivered ahead of schedule. On May 25, 2017, the Phase II implementation of these data elements into electronic registries and health records will be complemented by the acceleration of Phase III: the first clinical device trials using this structured approach to real world evidence quality and efficiency.
Join FDA, ONC, VQI, NCDR, SIR, VIVA, EPIC and the VA along with other informatics experts in laying out the road map solutions of working steps and timelines for implementation of the minimum core data elements to support device evaluation emerging from real world evidence that “dual purposes” rather than “doubles” site-based work flow.
Join the broad base of device manufacturers, regulators and clinicians in developing the first clinical trials emerging to support regulatory decisions in the PAD space using these principles of quality and efficiency aligned with the overall directions and priorities of the National Evaluation System for health Technologies (NEST).
Join the pre-competitive, collaborative RAPID working group within the MDEpiNet Public Private Partnership in Silver Spring Maryland on 25-May!